Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Mental Disease
Category
Pharmaceutical (4978)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1393)
Generic Drugs (128)
Infectious Disease (407)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (561)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)

Mental Disease Market Research Reports

We offer market research, industry forecasts, and business analysis in the Mental Disease as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

Filter
Title Search
1 - 25 of 98 Products Sort by Display
Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules
Sample Icon
Product code:228474
Published by GBI Research
Published January, 2012 Content info Pages: 87
Price US $ 3500
Alzheimer disease - new drugs, markets and companies
Product code:70927
Published by Jain Pharmabiotech
Published January, 2012 Content info  
Price US $ 3500
Product Profiles: Depression - Next generation vies for second-line patients
Sample Icon
Product code:203196
Published by Datamonitor
Published November, 2011 Content info Pages: 221
Price US $ 11400
Market and Product Forecasts: Depression - Agomelatine failure creates US market opportunity
Sample Icon
Product code:229427
Published by Datamonitor
Published October, 2011 Content info Pages: 48
Price US $ 11400
Product Profiles: Schizophrenia - Adjunctive treatments to carve new niche in mature market
Sample Icon
Product code:229416
Published by Datamonitor
Published October, 2011 Content info Pages: 193
Price US $ 11400
Major Depressive Disorder (MDD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sample Icon
Product code:222282
Published by GlobalData
Published October, 2011 Content info Pages: 100
Price US $ 3500
Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sample Icon
Product code:217929
Published by GlobalData
Published October, 2011 Content info Pages: 95
Price US $ 3500
Autistic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sample Icon
Product code:217225
Published by GlobalData
Published October, 2011 Content info Pages: 67
Price US $ 3500
Epidemiology: Attention Deficit Hyperactivity Disorder - Adult prevalence continues to be under-reported
Sample Icon
Product code:209098
Published by Datamonitor
Published August, 2011 Content info Pages: 33
Price US $ 5700
Key Companies: Depression - Leading players must adapt to remain competitive
Sample Icon
Product code:208199
Published by Datamonitor
Published August, 2011 Content info Pages: 40
Price US $ 3800
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 - 2015)
Sample Icon
Product code:208006
Published by Renub Research
Published August, 2011 Content info 65 Pages
Price US $ 850
Seroquel XR - Analysis and Estimates from 2007 to 2020
Sample Icon
Product code:217360
Published by GlobalData
Published July, 2011 Content info Pages: 29
Price US $ 2000
Invega Sustenna - Analysis and Forecasts from 2009 to 2020
Sample Icon
Product code:217343
Published by GlobalData
Published July, 2011 Content info Pages: 30
Price US $ 2000
Cariprazine - Analysis and Forecasts from 2013 to 2020
Sample Icon
Product code:217342
Published by GlobalData
Published July, 2011 Content info Pages: 26
Price US $ 2000
RG1678 - Analysis and Forecasts from 2014 to 2020
Sample Icon
Product code:217338
Published by GlobalData
Published July, 2011 Content info Pages: 30
Price US $ 2000
Abilify - Analysis and Estimates from 2002 to 2020
Sample Icon
Product code:217336
Published by GlobalData
Published July, 2011 Content info Pages: 32
Price US $ 2000
Zyprexa - Analysis and Forecasts from 2002 to 2018
Sample Icon
Product code:217334
Published by GlobalData
Published July, 2011 Content info Pages: 32
Price US $ 2000
Seroquel - Analysis and Estimates from 2002 to 2020
Sample Icon
Product code:217330
Published by GlobalData
Published July, 2011 Content info Pages: 32
Price US $ 2000
Risperdal Consta - Analysis and Forecasts from 2003 to 2020
Sample Icon
Product code:217329
Published by GlobalData
Published July, 2011 Content info Pages: 31
Price US $ 2000
Clozapine - Analysis and Forecasts from 2002 to 2020
Sample Icon
Product code:217327
Published by GlobalData
Published July, 2011 Content info Pages: 30
Price US $ 2000
Geodon - Analysis and Forecasts from 2002 to 2017
Sample Icon
Product code:217324
Published by GlobalData
Published July, 2011 Content info Pages: 29
Price US $ 2000
Zicronapine - Analysis and Forecasts from 2014 to 2020
Sample Icon
Product code:217322
Published by GlobalData
Published July, 2011 Content info Pages: 28
Price US $ 2000
Saphris - Analysis and Estimates from 2009 to 2020
Sample Icon
Product code:217319
Published by GlobalData
Published July, 2011 Content info Pages: 25
Price US $ 2000
Invega - Analysis and Forecasts from 2007 to 2020
Sample Icon
Product code:217312
Published by GlobalData
Published July, 2011 Content info Pages: 29
Price US $ 2000
Latuda - Analysis and Forecasts from 2011 to 2020
Sample Icon
Product code:217310
Published by GlobalData
Published July, 2011 Content info Pages: 32
Price US $ 2000